Portland, OR -- (SBWire) -- 06/20/2018 --In-Vitro Fertilization (IVF) services is an advanced reproductive technology, used in clinical laboratories to treat infertility caused by blocked fallopian tubes. This procedure is commonly applicable when women have absent or non-surgically repairable fallopian tubes, men with severe low sperm count, women with ovulatory dysfunction and endometriosis. The colloquial term for babies conceived through the IVF procedures is test-tube babies. In current scenario, IVF has evolving as an effective treatment for all causes of infertility, with a higher success rates.
Based on cycle type, the market is categorized into fresh cycle (non-donor), thawed IVF cycle (non-donor), and donor egg IVF cycle. Based on end users, the market is classified into fertility clinics, hospitals, surgical centers, and clinical research institute. By geography, the Asia-Pacific in-vitro fertilization market is analyzed across China, Japan, India, Australia, New Zealand, Korea, Thailand, Singapore, Malaysia, Indonesia, Philippines, Vietnam, Taiwan, and Rest of Asia-Pacific.
Request Sample Report:
Market Dynamics
Drivers
Increasing number of delayed parenthood cases in couples due to professional and financial constraints.
Growth in service sector of developing countries leading to stressful and anomalous lifestyle.
Rising geriatric population
Restraints
Ethical issues related to the use of IVF technology.
High cost of the IVF procedure
Hospitals and Clinics
The top players in the Asia-Pacific In-Vitro Fertilization (IVF) services market are IVF Namba Clinic, Reproductive and Genetic Hospital Citic-Xiangya, Bourn Hall Clinic, Flinders Fertility Clinic, Fertility PLUS, Repromed IVF Adelaide, MARIA Fertility Hospital, Bangkok Fertility Center, Ramathibodi Hospital, Siloam Hospitals Surabaya, Siriraj Hospital, Iwaki Womens Clinic, Centre for Reproductive Medicine, Monash IVF, and City Fertility Centre IVF Clinic.
KEY TAKEAWAY
Asia-Pacific In-Vitro Fertilization (IVF) Services Market
MARKET LANDSCAPE
By Cycle Type
Fresh Cycle (Non-Donor)
Thawed IVF Cycle (Non-Donor)
Donor Egg IVF Cycles
By End-User
Fertility Clinics
Hospitals
Surgical Centers
Clinical Research Institutes
By Geography
China
Japan
India
Australia
New Zealand
Korea
Thailand
Singapore
Malaysia
Indonesia
Philippines
Vietnam
Taiwan
Rest of Asia-Pacific
Asia-Pacific in-Vitro Fertilization (IVF) Services Market Future Trend, 2025
The Asia-pacific In-Vitro Fertilization (IVF) services market is expected to grow at a CAGR of 14.1% from 2017 to 2025.